Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
54
NMPA:54
Drug Approvals
Hydroxyethyl Starch 40 Sodium Chloride Injection
- Product Name
- 羟乙基淀粉40氯化钠注射液
- Approval Number
- 国药准字H61023034
- Approval Date
- Jan 27, 2025
NMPA
Hydroxyethyl Starch 40 Sodium Chloride Injection
- Product Name
- 羟乙基淀粉40氯化钠注射液
- Approval Number
- 国药准字H61023033
- Approval Date
- Jan 27, 2025
NMPA
Ribavirin and Glucose Injection
- Product Name
- 利巴韦林葡萄糖注射液
- Approval Number
- 国药准字H20045506
- Approval Date
- Jan 21, 2025
NMPA
Compound Sodium Acetate Injection
- Product Name
- 复方醋酸钠注射液
- Approval Number
- 国药准字H61022728
- Approval Date
- Aug 18, 2020
NMPA
Dextran 40 and Glucose Injection
- Product Name
- 右旋糖酐40葡萄糖注射液
- Approval Number
- 国药准字H61023444
- Approval Date
- Aug 18, 2020
NMPA
Ofloxacin And Glucose Injection
- Product Name
- 氧氟沙星葡萄糖注射液
- Approval Number
- 国药准字H20058163
- Approval Date
- Aug 18, 2020
NMPA
Compound Sodium Acetate Injection
- Product Name
- 复方醋酸钠注射液
- Approval Number
- 国药准字H61022833
- Approval Date
- Aug 18, 2020
NMPA
Metronidazole And Sodium Chloride Injection
- Product Name
- 甲硝唑氯化钠注射液
- Approval Number
- 国药准字H61023380
- Approval Date
- Aug 18, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
Clinical Trials
No trials found
News
No news found